AR112343A1 - Composiciones de anticuerpos estabilizadas y métodos para producirlas - Google Patents
Composiciones de anticuerpos estabilizadas y métodos para producirlasInfo
- Publication number
- AR112343A1 AR112343A1 ARP180102059A AR112343A1 AR 112343 A1 AR112343 A1 AR 112343A1 AR P180102059 A ARP180102059 A AR P180102059A AR 112343 A1 AR112343 A1 AR 112343A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- produce
- antibody compositions
- oxygen
- stabilized antibody
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 239000011800 void material Substances 0.000 abstract 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 229940126534 drug product Drugs 0.000 abstract 2
- 239000007789 gas Substances 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 102000025171 antigen binding proteins Human genes 0.000 abstract 1
- 108091000831 antigen binding proteins Proteins 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2068—Venting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/10—Analysis or design of chemical reactions, syntheses or processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Fluid Mechanics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pathology (AREA)
- Theoretical Computer Science (AREA)
- Computing Systems (AREA)
- Hydrology & Water Resources (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Productos farmacológicos que comprenden recipientes sellados que contienen una proteína recombinante líquida estable, como una proteína de unión a antígeno, una composición y un gas de espacio vacío que comprende menos del 5% de oxígeno y métodos para producirlos. Proporciona un método para controlar los niveles de oxígeno en el espacio vacío de un producto farmacológico en un recipiente sellado que comprende una composición de proteína recombinante líquida estable y un gas de espacio vacío que comprende menos del 21% de oxígeno.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762536028P | 2017-07-24 | 2017-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112343A1 true AR112343A1 (es) | 2019-10-16 |
Family
ID=63259557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180102059 AR112343A1 (es) | 2017-07-24 | 2018-07-24 | Composiciones de anticuerpos estabilizadas y métodos para producirlas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20190021952A1 (es) |
| EP (1) | EP3658580A1 (es) |
| JP (2) | JP7389017B2 (es) |
| KR (1) | KR102694151B1 (es) |
| CN (1) | CN111051340A (es) |
| AR (1) | AR112343A1 (es) |
| AU (1) | AU2018307610B2 (es) |
| BR (1) | BR112020001454A2 (es) |
| CA (1) | CA3070214A1 (es) |
| EA (1) | EA202090350A1 (es) |
| IL (1) | IL272058B2 (es) |
| MX (1) | MX2020000918A (es) |
| SG (1) | SG11202000363XA (es) |
| TW (2) | TW202348250A (es) |
| WO (1) | WO2019023102A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202348250A (zh) * | 2017-07-24 | 2023-12-16 | 美商再生元醫藥公司 | 穩定化之抗體組合物及其製法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2371427A1 (en) * | 1999-04-28 | 2000-11-09 | Yamanouchi Pharmaceutical Co., Ltd. | Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof |
| US6274169B1 (en) * | 1999-08-02 | 2001-08-14 | Abbott Laboratories | Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol |
| CA2518903C (en) * | 2003-04-02 | 2013-02-05 | Ares Trading S.A. | Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| CA2766220C (en) | 2009-06-26 | 2021-02-09 | Regeneron Pharmaceuticals, Inc. | Readily isolated bispecific antibodies with native immunoglobulin format |
| WO2011008770A2 (en) | 2009-07-14 | 2011-01-20 | Biogen Idec Ma Inc. | Methods for inhibiting yellow color and peroxide formation in a composition |
| PL2505654T5 (pl) | 2010-02-08 | 2020-11-30 | Regeneron Pharmaceuticals, Inc. | Mysz ze wspólnym łańcuchem lekkim |
| EP2361636A1 (en) * | 2010-02-26 | 2011-08-31 | CSL Behring AG | Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| SI2601105T1 (sl) * | 2010-08-06 | 2017-12-29 | Hospira Australia Pty Ltd | Sistem in metoda za pripravo viale |
| TWI635098B (zh) | 2013-02-01 | 2018-09-11 | 再生元醫藥公司 | 含嵌合恆定區之抗體 |
| US10016449B2 (en) | 2013-05-28 | 2018-07-10 | Momenta Pharmaceuticals, Inc. | Pharmaceutical compositions |
| EP3763384B1 (en) * | 2014-12-03 | 2024-08-28 | CSL Behring AG | Pharmaceutical product with increased stability comprising immunoglobulins |
| AR103173A1 (es) * | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| US20180043020A1 (en) * | 2016-04-20 | 2018-02-15 | Coherus Biosciences, Inc. | Method of reducing immunogenicity of drug products |
| TW202348250A (zh) * | 2017-07-24 | 2023-12-16 | 美商再生元醫藥公司 | 穩定化之抗體組合物及其製法 |
-
2018
- 2018-07-20 TW TW112129700A patent/TW202348250A/zh unknown
- 2018-07-20 TW TW107125081A patent/TWI865430B/zh active
- 2018-07-23 KR KR1020207005312A patent/KR102694151B1/ko active Active
- 2018-07-23 EA EA202090350A patent/EA202090350A1/ru unknown
- 2018-07-23 WO PCT/US2018/043238 patent/WO2019023102A1/en not_active Ceased
- 2018-07-23 SG SG11202000363XA patent/SG11202000363XA/en unknown
- 2018-07-23 IL IL272058A patent/IL272058B2/en unknown
- 2018-07-23 EP EP18756516.3A patent/EP3658580A1/en active Pending
- 2018-07-23 JP JP2020503731A patent/JP7389017B2/ja active Active
- 2018-07-23 US US16/042,099 patent/US20190021952A1/en active Pending
- 2018-07-23 MX MX2020000918A patent/MX2020000918A/es unknown
- 2018-07-23 AU AU2018307610A patent/AU2018307610B2/en not_active Expired - Fee Related
- 2018-07-23 CA CA3070214A patent/CA3070214A1/en active Pending
- 2018-07-23 CN CN201880055667.8A patent/CN111051340A/zh active Pending
- 2018-07-23 BR BR112020001454-0A patent/BR112020001454A2/pt not_active Application Discontinuation
- 2018-07-24 AR ARP180102059 patent/AR112343A1/es unknown
-
2023
- 2023-09-28 JP JP2023167566A patent/JP2023182677A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3658580A1 (en) | 2020-06-03 |
| TW202348250A (zh) | 2023-12-16 |
| TWI865430B (zh) | 2024-12-11 |
| CA3070214A1 (en) | 2019-01-31 |
| JP2023182677A (ja) | 2023-12-26 |
| IL272058B2 (en) | 2025-01-01 |
| JP7389017B2 (ja) | 2023-11-29 |
| KR20200031676A (ko) | 2020-03-24 |
| KR102694151B1 (ko) | 2024-08-12 |
| JP2020528427A (ja) | 2020-09-24 |
| IL272058B1 (en) | 2024-09-01 |
| AU2018307610B2 (en) | 2025-02-27 |
| EA202090350A1 (ru) | 2020-06-22 |
| WO2019023102A1 (en) | 2019-01-31 |
| SG11202000363XA (en) | 2020-02-27 |
| TW201919582A (zh) | 2019-06-01 |
| BR112020001454A2 (pt) | 2020-07-28 |
| AU2018307610A1 (en) | 2020-02-06 |
| MX2020000918A (es) | 2020-09-18 |
| CN111051340A (zh) | 2020-04-21 |
| US20190021952A1 (en) | 2019-01-24 |
| IL272058A (en) | 2020-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017010400A (es) | Formulacion liquida estable para anticuerpos monoclonales. | |
| MX2016016216A (es) | Metodo para el tratamiento del cabello con un acondicionador concentrado. | |
| CL2016001837A1 (es) | Dispositivo y procedimiento para la codosificación. | |
| MX2016009440A (es) | Polvo de titanio que contiene nitrógeno en solución sólida, material de titanio, y método para producir polvo de titanio que contiene nitrógeno en solución sólida. | |
| AR082585A1 (es) | Productos dulces congelados con un estabilizante natural | |
| BR112017010442A2 (pt) | produto farmacêutico, usos de uma seringa de polímero, de um composto sequestrante de oxigênio, e de uma solução de imunoglobulina | |
| CL2017001098A1 (es) | Un envase flexible mejorado, para empaquetar productos frescos, hecho de una película flexible biodegradable | |
| AR088807A1 (es) | Cierre para un recipiente que contiene un producto, metodo de producir dicho cierre y recipiente que contiene dicho cierre | |
| AR099427A1 (es) | Métodos para el envasado aséptico de alimentos de baja acidez | |
| ES2530841T3 (es) | Generación de plasma de CO para envasado en atmósfera modificada | |
| AR100618A1 (es) | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido | |
| EA201692014A1 (ru) | Улучшитель теста и хлеба | |
| CO2017000914A2 (es) | Aparatos y métodos para envolver un relleno en un producto alimentario | |
| MX2021002049A (es) | Productos que contienen cannabinoides, contenedores, sistemas y métodos. | |
| MX2019002980A (es) | Procedimiento de envasado de capsulas alimenticias y producto alimenticio envasado obtenido mediante el mismo. | |
| MX366953B (es) | Composición farmacéutica que no contiene antioxidantes y método de preparación de la misma. | |
| MX2022000915A (es) | Metodo para prolongar la viabilidad de esporas fungicas en formulaciones liquidas. | |
| MX390480B (es) | Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas. | |
| AR112343A1 (es) | Composiciones de anticuerpos estabilizadas y métodos para producirlas | |
| BR112016016690A2 (pt) | processo para a reconstituição de uma forma sólida de uma composição farmacêutica | |
| PH12017501828A1 (en) | Stabilized pharmaceutical composition and method for preparing same | |
| MX2015014544A (es) | Disposicion para preparacion rapida de productos susceptibles de ser encapsulados. | |
| EA201171440A1 (ru) | Способ ароматизации размещаемого в упаковке пищевого продукта | |
| AR096663A1 (es) | Aparato, método y sistema para reducir el contenido de oxígeno en el envase de un producto | |
| BR112017013881A2 (pt) | ?produto, método para a utilização do produto, composição de produtos lácteos fermentados, método para a preparação de uma composição e utilização de cmp? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |